Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adverse Event Reports Hit All-Time High; FDA Warns Firms About MDRs, Complaint Handling

This article was originally published in The Silver Sheet

Executive Summary

As FDA sifts through almost a million Medical Device Reports submitted by manufacturers last year, the agency is trying to determine why so many adverse events are being reported. Isaac Chang, a director in CDRH’s Office of Surveillance and Biometrics, speculates that there could be a number of reasons for the large influx of MDRs, including high-profile recalls and a sharper FDA focus on human factors issues. Further, more than half of adverse events were reported to the agency on individual MedWatch forms in 2012 – a sharp increase over previous years. However, despite the extraordinary rise in reports, some firms continue to have trouble developing MDR procedures. Industry experts also weigh in on social media’s impact on adverse event reporting, and tips are shared for ensuring that complaints are properly handled by manufacturers.

Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT036689

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel